EarningsCENTRALPHL
CENTRALPHL Earnings Update
Announcement summary
- What happened
- CENTRALPHL published a corporate disclosure on 12 November 2023. Read the full announcement for details.
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
(Q1 Un-audited): EPS was Tk. (0.05) for July-September, 2023 as against Tk. (0.08) for July-September, 2022. NOCFPS was Tk. (0.00) for July-September, 2023 as against Tk. 0.00 for July-September, 2022. NAV per share was Tk. 5.54 as on September 30, 2023 and Tk. 5.59 as on June 30, 2023.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65504cd09b63f8421286d3a0
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.